{"id":9046,"date":"2020-08-17T19:59:00","date_gmt":"2020-08-17T19:59:00","guid":{"rendered":"https:\/\/polpharmabiologics.com\/?p=9046"},"modified":"2025-03-25T15:27:58","modified_gmt":"2025-03-25T15:27:58","slug":"polpharma-biologics-the-polish-biosimilar-powerhouse","status":"publish","type":"post","link":"https:\/\/polpharmabiologics.com\/pl\/polpharma-biologics-the-polish-biosimilar-powerhouse\/","title":{"rendered":"Polpharma Biologics \u2013 The Polish biosimilar powerhouse"},"content":{"rendered":"\n<p><em>\u201cOther companies come to us and want CDMO work in the biosimilar space because we know what we\u2019re doing, but our goal is not to become 100% biosimilars. Our goal is to become a leading biologics manufacturer and biosimilars are a part of what we do,\u201d<\/em>&nbsp;said our Vice President of Strategy, Programs and Portfolio \u2013&nbsp;<strong>Alexandra Moulson<\/strong>&nbsp;in an interview with The Center for Biosimilars\u00ae.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.centerforbiosimilars.com\/view\/polpharma-biologics-the-polish-biosimilar-powerhouse\"><u><strong>Read the full interview<\/strong><\/u><\/a>&nbsp;and find out more about Polpharma Biologics CDMO services, forward expansion and whether COVID-19 had an impact on the company in recent months.<br>&nbsp;<\/p>\n\n\n\n<p><strong>Alexandra Moulson<\/strong><br>Vice President of Strategy, Programs and Portfolio at Polpharma Biologics<\/p>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/polpharmabiologics.com\/uploads\/post\/Alexandra-Moulson-5f86d56b4277d.jpeg\" alt=\"Alexandra Moulson\"\/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>\u201cOther companies come to us and want CDMO work in the biosimilar space because we know what we\u2019re doing, but our goal&#8230;<\/p>\n","protected":false},"author":7,"featured_media":7365,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[33],"class_list":["post-9046","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-artykuly","tag-wywiady"],"_links":{"self":[{"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/posts\/9046","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/comments?post=9046"}],"version-history":[{"count":0,"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/posts\/9046\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/media\/7365"}],"wp:attachment":[{"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/media?parent=9046"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/categories?post=9046"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/tags?post=9046"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}